Originally published April 28, 2008 at 12:00 AM | Page modified April 28, 2008 at 5:46 PM
Mediquest asks for FDA approval of drug
Mediquest Therapeutics said today that it requested approval by federal regulators of its experimental therapy to treat Raynaud's disease...
Seattle Times business reporter
Mediquest Therapeutics said today that it requested approval by federal regulators of its experimental therapy to treat Raynaud's disease.
The U.S. Food and Drug Administration must accept the submission before it reviews the drug's effectiveness. Even if the FDA agrees to study the therapy, a topical cream that treats a painful vascular ailment, the approval process could take several months.
The submission, however, puts the closely held Bothell pharmaceutical company in the small club of Seattle-area firms that have filed a new drug application with the FDA. Others include ZymoGenetics, Immunex and Icos.
"After less than six years of research and clinical trials, submitting our application is a major accomplishment and milestone for our company as we move closer to bringing this treatment to market for the millions of patients who suffer from the symptoms of Raynaud's disease," said Mediquest Chief Executive Frederick Dechow.
The company announced encouraging results from a late-stage clinical trial last November.
Ángel González: 206-515-5644 or agonzalez@seattletimes.com
Copyright © 2008 The Seattle Times Company
An 802.11n upgrade could make a big difference
Retailers opening doors on Thanksgiving Day
Google makes concessions on digital book deal
Critics want to block Comcast-NBC deal
Google submits revised book settlement

Girls Soccer: Mercer Island vs. Glacier Peak
Mercer Island defeats Glacier Peak, 2-1, in a 3A state playoff quarterfinal on Saturday, Nov. 14.
nwjobs

Post a comment

Michelle Goodman blogs about work/life balance.
How to tell your office you're gravely ill
Post a comment
nwautos

Choosing a new sedan? Weigh the impact of your choice on your wallet and on the planet.
Post a comment
- Homeless man, 46, arrested in Greenwood arsons
- KVI talk radio host off the air as of Thursday
- Steve Kelley | ESPN's Bill Simmons gets us: He hates Clay Bennett, too
- Police investigate videotaped arrest
- Seattle U. Men's Hoops | Big recruit goes from Huskies to Redhawks
- Mariners sign Jack Wilson to 2-year contract
- Razor found in muffin an accident, 'mortified' baker says
- Suspect's family shaken by slaying of police officer
- Mountlake Terrace woman reports razor in muffin
- Man says he will protest city's gun ban by carrying gun into community center
- OSU game thread
713 - Seattle man to pack a pistol into community center to protest mayor's ban
358 - Kent man challenges Seattle Mayor Greg Nickels' gun ban
140 - NYC trial for 9/11 suspects poses risks
137 - Belmont game thread
114 - Band of advocates, activists now McGinn's likely insiders
114 - Licata looks at boosting traffic-ticket revenue
93 - Light rail to airport to begin Dec. 19
84 - A politically correct — and dangerous — delicacy about the Fort Hood shooting
70 - Huskies no match for Oregon State, fall 48-21
69
- Light rail to airport to begin Dec. 19
- Homeless man, 46, arrested in Greenwood arsons
- Ivar's undersea billboards a hoax devised as marketing ploy
- Light rail to airport to begin Dec. 19
- Steve Kelley | ESPN's Bill Simmons gets us: He hates Clay Bennett, too
- An 802.11n upgrade could make a big difference
- KVI talk radio host off the air as of Thursday
- Washington in race for federal education funds
- Police investigate videotaped arrest
- Charles Krauthammer / Syndicated columnist | A politically correct — and dangerous — delicacy about the Fort Hood shooting





